A gloved hand holds a vial of mpox vaccine
Upstream & Downstream ProcessingIn the race to stop mpox, GeoVax prepares for a marathonIn the race to stop mpox, GeoVax prepares for a marathon
Vaccine maker GeoVax is readying one of two modified vaccinia Ankara (MVA) candidates for Phase III clinical trials before the end of 2025.
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.